B · Normal
[The traditional Chinese medicine sector is active against the trend, and Lingrui Pharmaceutical has hit its daily limit] News on October 30th, the traditional Chinese medicine sector was active against the trend in early trading, with Lingrui Pharmaceutical hitting its daily limit. Previously, Guilin Sanjin had gone out of the two-game board, and Buchang Pharmaceutical, Sunflower Pharmaceutical, Jilin Aodong, and Kangmei Pharmaceutical soared. On the news, Lingrui Pharmaceutical released its third quarter report, which showed that the company’s single-quarter net profit in the third quarter increased by 26.71% year-on-year.
Comments